Company intelligence / Profile preview

Jilin Province Jinkangan Pharmaceutical

Dunhua, Jilin Province, China

Ownership: Private
Development stage: Other

Overview

Jilin Province Jinkangan Pharmaceutical is a Chinese pharmaceutical company engaged in the sales of medicines and production of medical devices, with a focus on hospital markets across China. The company is involved in translational research, including circulating tumor cell methylation profiling for non-small cell lung cancer (NSCLC)[8]. Its subsidiary, Jin Kang An Medical, specializes in R&D, production, and sales of Class-II and Class-III medical devices for ICU, anesthesia, and respiratory care[10].

Modalities: Small moleculeMedical device
Industry: Molecular Diagnostics

Partnerships

Daeyomedi Corporation (South Korea)Seoil Pacific Corporation (South Korea)BrainU Corporation(South Korea)Mespere Lifesciences (Canada)

Beyond the preview

Go deeper on Jilin Province Jinkangan Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jilin Province Jinkangan Pharmaceutical.

Explore the full profile